Latest trade
$487.4BGlobal subsector valueHS4 subsector intelligence
Medicaments
HS4 3004 trade overview
A focused view of this HS4 subsector: market scale, momentum, leading routes, countries, and the HS6 classifications inside it.
The numbers at a glanceLatest reported year · 2024
Annual change
-0.6%Latest year on yearExporters
195Active reporting countriesImporters
200Active reporting countriesHS6 products
12Classifications inside HS4The subsector read
$487.4B in trade, with +4.6% annualized growth over three years.
Medicaments is recorded across 11,731 active corridors, with 195 exporters and 200 importers.
Annual trend
Subsector momentum over time
Reported global trade from 1995 to 2024. Read the methodology ↗
Top trade corridors
Where the subsector moves
Leading exporter-to-importer relationships by latest reported value. See data sources ↗
Latest reported relationshipsTop 10 by trade value
| Rank | Exporter | Importer | Trade value | Growth | HS6 | Distance | FTA |
|---|---|---|---|---|---|---|---|
| 1 | SloveniaSVN | Switzerland, LiechtensteinCHE | $19.7B | +83% | 7 | 481 km | Yes |
| 2 | Switzerland, LiechtensteinCHE | USA, Puerto Rico and US Virgin IslandsUSA | $13.6B | -5.7% | 9 | 6,339 km | No |
| 3 | IrelandIRL | USA, Puerto Rico and US Virgin IslandsUSA | $11.1B | +0.9% | 9 | 5,129 km | No |
| 4 | IndiaIND | USA, Puerto Rico and US Virgin IslandsUSA | $10.3B | +10.8% | 11 | 11,771 km | No |
| 5 | GermanyDEU | USA, Puerto Rico and US Virgin IslandsUSA | $9.3B | -4.8% | 11 | 6,402 km | No |
| 6 | ItalyITA | Switzerland, LiechtensteinCHE | $8.5B | +41% | 9 | 684 km | Yes |
| 7 | ItalyITA | USA, Puerto Rico and US Virgin IslandsUSA | $7.8B | +28.4% | 10 | 6,907 km | No |
| 8 | CanadaCAN | USA, Puerto Rico and US Virgin IslandsUSA | $7.4B | +8.4% | 11 | 556 km | Yes |
| 9 | ItalyITA | BelgiumBEL | $6.8B | +4.9% | 9 | 1,174 km | Yes |
| 10 | Switzerland, LiechtensteinCHE | SloveniaSVN | $6.2B | +15.5% | 9 | 481 km | Yes |
Market structure
Where supply and demand concentrate
Exporter and importer rankings show the two sides of the subsector separately. Check coverage ↗
| Rank | Country | Exports | Partners | HS6 |
|---|---|---|---|---|
| 1 | GermanyDEU | $67.4B | 185 | 12 |
| 2 | Switzerland, LiechtensteinCHE | $45.0B | 181 | 12 |
| 3 | ItalyITA | $43.2B | 173 | 12 |
| 4 | USA, Puerto Rico and US Virgin IslandsUSA | $37.3B | 187 | 12 |
| 5 | IrelandIRL | $30.2B | 160 | 12 |
| 6 | FranceFRA | $27.8B | 190 | 12 |
| 7 | SloveniaSVN | $26.7B | 139 | 12 |
| 8 | BelgiumBEL | $23.8B | 177 | 12 |
| 9 | IndiaIND | $23.2B | 196 | 12 |
| 10 | United KingdomGBR | $18.1B | 188 | 12 |
| Rank | Country | Imports | Partners | HS6 |
|---|---|---|---|---|
| 1 | USA, Puerto Rico and US Virgin IslandsUSA | $95.0B | 112 | 12 |
| 2 | Switzerland, LiechtensteinCHE | $45.3B | 118 | 12 |
| 3 | GermanyDEU | $31.9B | 105 | 12 |
| 4 | BelgiumBEL | $21.6B | 117 | 12 |
| 5 | ChinaCHN | $20.5B | 82 | 12 |
| 6 | United KingdomGBR | $18.3B | 105 | 12 |
| 7 | ItalyITA | $17.3B | 89 | 12 |
| 8 | FranceFRA | $16.8B | 147 | 12 |
| 9 | JapanJPN | $14.7B | 72 | 12 |
| 10 | SpainESP | $14.1B | 88 | 12 |
HS6 product coverage
The products inside HS4 3004
Six-digit classifications make the subsector specific. Browse the product workspace ↗
13 classifications shownMedicaments
Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail saleHS6 300410
Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail saleHS6 300420
Medicaments: containing insulin, for therapeutic or prophylactic uses, packaged for retail saleHS6 300431
Medicaments: containing corticosteroid hormones, their derivatives or structural analogues (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail saleHS6 300432
Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail saleHS6 300439
Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail saleHS6 300440
Medicaments: containing alkaloids or their derivatives, containing ephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail saleHS6 300441
Medicaments: containing alkaloids or their derivatives, containing pseudoephedrine (INN) or its salts, for therapeutic or prophylactic uses, packaged for retail saleHS6 300442
Medicaments: containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail saleHS6 300443
Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail saleHS6 300449
Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail saleHS6 300450
Medicaments: containing antimalarial active principles described in Subheading Note 2 to this Chapter, for therapeutic or prophylactic uses, packaged for retail saleHS6 300460
Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail saleHS6 300490
Definitions and coverage
Read the numbers with context
Reported observations and calculated indicators should be read with their coverage period. Responsible AI principles ↗
Reported values
Trade values describe reported merchandise trade for the HS4 classification, not company-level sales or shipment records.
Calculated indicators
Growth, concentration, volatility, and peak comparisons are calculated from reported observations.
Missing data
Unavailable observations remain unavailable. They are not filled, interpolated, or presented as forecasts.
Coverage: 1995-2024 · Data refreshed 2026-07-20 09:34:09
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-27). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.